These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 24775272)

  • 21. Apolipoprotein A5 and apolipoprotein C3 single nucleotide polymorphisms are correlated with an increased risk of coronary heart disease: a case-control and meta-analysis study.
    Yang G; Lei MM; Yu CL; Liu XX; An Z; Song CL
    Lipids Health Dis; 2015 Sep; 14():113. PubMed ID: 26387083
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The -1131T-->C polymorphism in the apolipoprotein A5 gene is associated with postprandial hypertriacylglycerolemia; elevated small, dense LDL concentrations; and oxidative stress in nonobese Korean men.
    Jang Y; Kim JY; Kim OY; Lee JE; Cho H; Ordovas JM; Lee JH
    Am J Clin Nutr; 2004 Oct; 80(4):832-40. PubMed ID: 15447887
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of the apolipoprotein A5 gene -1131 T>C polymorphism with fasting blood lipids: a meta-analysis in 37859 subjects.
    Zhao T; Zhao J
    BMC Med Genet; 2010 Aug; 11():120. PubMed ID: 20696075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apolipoprotein E isoform polymorphisms are not associated with insulin resistance: the Framingham Offspring Study.
    Meigs JB; Ordovas JM; Cupples LA; Singer DE; Nathan DM; Schaefer EJ; Wilson PW
    Diabetes Care; 2000 May; 23(5):669-74. PubMed ID: 10834428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between the distribution of plasma HDL subclasses and the polymorphisms of APOA5 in hypertriglyceridemia.
    Long S; Chen Z; Han Y; Christopher DM; Zhang C; Yang Y; Tian Y
    Clin Biochem; 2013 Jun; 46(9):733-9. PubMed ID: 23499587
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The apolipoprotein A5 -1131T>C promoter polymorphism in Koreans: association with plasma APOA5 and serum triglyceride concentrations, LDL particle size and coronary artery disease.
    Jang Y; Paik JK; Hyun YJ; Chae JS; Kim JY; Choi JR; Lee SH; Shin DJ; Ordovas JM; Lee JH
    Clin Chim Acta; 2009 Apr; 402(1-2):83-7. PubMed ID: 19159622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of APOA5 and APOC3 gene polymorphisms with plasma apolipoprotein A5 level in patients with metabolic syndrome.
    Niculescu LS; Vlădică M; Sima AV
    Biochem Biophys Res Commun; 2010 Jan; 391(1):587-91. PubMed ID: 19932084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Supplementation with two probiotic strains, Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032, reduces fasting triglycerides and enhances apolipoprotein A-V levels in non-diabetic subjects with hypertriglyceridemia.
    Ahn HY; Kim M; Chae JS; Ahn YT; Sim JH; Choi ID; Lee SH; Lee JH
    Atherosclerosis; 2015 Aug; 241(2):649-56. PubMed ID: 26117402
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of APOA5 -1131T>C (rs662799) on fasting plasma lipids and risk of metabolic syndrome: evidence from a case-control study in China and a meta-analysis.
    Xu C; Bai R; Zhang D; Li Z; Zhu H; Lai M; Zhu Y
    PLoS One; 2013; 8(2):e56216. PubMed ID: 23468858
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Association of APOA5 gene polymorphism with levels of lipids and atherosclerotic cerebral infarction in Chinese].
    Li J; Xu HW; Zhu XY
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Oct; 24(5):576-8. PubMed ID: 17922432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. APOA5 gene polymorphism modulates levels of triglyceride, HDL cholesterol and FERHDL but is not a risk factor for coronary artery disease.
    Lee KW; Ayyobi AF; Frohlich JJ; Hill JS
    Atherosclerosis; 2004 Sep; 176(1):165-72. PubMed ID: 15306190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Relation between Metabolic Syndrome Risk Factors and Genetic Variations of Apolipoprotein V in Relation with Serum Triglyceride and HDL-C Level.
    Fallah MS; Sedaghatikhayat B; Guity K; Akbari F; Azizi F; Daneshpour MS
    Arch Iran Med; 2016 Jan; 19(1):46-50. PubMed ID: 26702748
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of APOA5 and APOC3 variants on lipid parameters in European Whites, Indian Asians and Afro-Caribbeans with type 2 diabetes.
    Dorfmeister B; Cooper JA; Stephens JW; Ireland H; Hurel SJ; Humphries SE; Talmud PJ
    Biochim Biophys Acta; 2007 Mar; 1772(3):355-63. PubMed ID: 17197160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Associations of the apolipoprotein A1/C3/A4/A5 gene cluster with triglyceride and HDL cholesterol levels in women with type 2 diabetes.
    Qi L; Liu S; Rifai N; Hunter D; Hu FB
    Atherosclerosis; 2007 May; 192(1):204-10. PubMed ID: 16781717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The apolipoprotein A5 (APOA5) gene predisposes Caucasian children to elevated triglycerides and vitamin E (Four Provinces Study).
    Guardiola M; Ribalta J; Gómez-Coronado D; Lasunción MA; de Oya M; Garcés C
    Atherosclerosis; 2010 Oct; 212(2):543-7. PubMed ID: 20688329
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apolipoprotein A-IV polymorphism, and its role in determining variation in lipoprotein-lipid, glucose and insulin levels in normal and non-insulin-dependent diabetic individuals.
    Kamboh MI; Hamman RF; Iyengar S; Aston CE; Ferrell RE
    Atherosclerosis; 1991 Nov; 91(1-2):25-34. PubMed ID: 1811553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Longitudinal analysis of haplotypes and polymorphisms of the APOA5 and APOC3 genes associated with variation in serum triglyceride levels: the Bogalusa Heart Study.
    Hallman DM; Srinivasan SR; Chen W; Boerwinkle E; Berenson GS
    Metabolism; 2006 Dec; 55(12):1574-81. PubMed ID: 17142127
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of APOA5 S19W polymorphism on growth, insulin sensitivity and lipoproteins in normoweight neonates.
    Gesteiro E; Bastida S; Vázquez-Velasco M; Corella D; Guillén M; Ordovas JM; Sánchez-Muniz FJ
    Eur J Pediatr; 2011 Dec; 170(12):1551-8. PubMed ID: 21505768
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship of apolipoprotein A5 and apolipoprotein C3 levels to serum triglycerides in patients with type 2 diabetes.
    Alborn WE; Prince MJ; Konrad RJ
    Clin Chim Acta; 2007 Mar; 378(1-2):154-8. PubMed ID: 17188674
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A case-control study of apoA5 -1131T-->C polymorphism that examines the role of triglyceride levels in diabetic nephropathy.
    Baum L; Ng MC; So WY; Poon E; Wang Y; Lam VK; Tomlinson B; Chan JC
    J Diabetes Complications; 2007; 21(3):158-63. PubMed ID: 17493548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.